Summary

Work experience

• Executive Director

  Dyne Therapeutics

  2025.02-Current

  (a year)

  Navigating Legal and IP landscape for a rare disease company launching its first product. Improve and build internal framework for Legal/IP to properly support Research, CMC, translational sciences, clinical operations, medical, and commercial departments. Advise the company on potential litigation risks and implement strategies. Facilitate due diligence efforts and other transactional needs.
• Executive Director and Head of IP

  Innovent Biologics

  2022.10-2025.02

  (2 years)

  Led a team of 14 IP professionals, handling all aspects of IP globally for a 6,000 employee corporation. Led international legal, handling international collaboration, dispute resolution and other legal projects overseas. Guided cross-functional efforts in the strategic planning of global organizational structure and new-co endeavors. Navigated geographical risks faced by the corporations’ presence in different jurisdictions. Implemented IP framework integrating with different departments. Participated in and led international partnership negotiations, coordinating Legal, IP and other functions. Led contract negotiations for multiple international deals, and contract amendments. Performed due diligence on various projects for in-license, out-license, and investments.
• Associate Director, IP and Litigation

  Seagen Inc. (formerly Seattle Genetics)

  2019.04-2022.09

  (3 years)

  Seagen Inc.,Associate Director, IP and Litigation, US Oct 2021 – Sep 2022 Seagen Inc., Litigation Counsel, Bothell, WA Oct 2020 – Oct 2021 Seagen Inc., Patent Counsel, Bothell, WA Apr 2019 – Oct 2020 Designed and executed IP strategy for protecting therapeutic candidates; summarized and reported on exclusivity (LOE), including market exclusivity and patent exclusivity on key programs. Navigated regulatory and IP regimens of different countries to maximize IP and data exclusivity around the globe. Advised management and key functions of business on IP implications and IP risks. Engaged in evaluation of potential IP disputes to assist business decision making. Participated in and partially handled high-stake IP and contractual disputes in Europe and U.S., in courts and in international arbitration. Participated in advising top executives and Board members on litigation progress, litigation strategy, outcome prospects, settlement evaluations and settlement discussions for high-stake IP and contractual disputes. Led IP drafting and negotiations in business transactions including licensing, acquisition, and collaborations. Provided IP advice to research, development, commercial, HR, compliance and privacy functions.
• Associate

  Seed IP

  2018.07-2019.03

  (9 months)

  Advised clients on IP strategy in light of FDA regulatory law/rules. Managed patent portfolios worldwide; analyzed competitive landscape, invalidity and infringement. Conducted due diligence and advised on contracts for clients including Juno, Denali, and Sana Biotech.
• Associate

  Fish & Richardson, Boston & Silicon Valley Offices, US

  2014.10-2018.06

  (4 years)
• Summer Associate

  Fish & Richardson

  2013.05-2013.07

  (3 months)

  Practiced patent litigation at Federal District Courts in various phases including pre-suit investigation, discovery,motion practice, expert report, and pre-trial preparation. Gilead v. AbbVie; Corel v. Microsoft. Participated in a Section 337 investigation at the International Trade Commission (ITC). Illumina v. Oxford Nanopore Technology Counseled clients on post-grant proceedings including Inter Partes Review; prosecuted Trademark applications. Drafted patent applications and prosecuted patents worldwide on large molecule pharmaceuticals, and in particular therapeutic antibodies.
• Intern with Judge William G. Young

  U.S. District Court for the District of Massachusetts

  2013.01-2013.05

  (5 months)

  Drafted opinion in a Veteran’s Benefit Appeal – Blessing v. Colvin, 951 F. Supp. 2d 367 (N.D.N.Y. 2013). Prepared bench memoranda on various issues in housing, mortgage, and Intellectual Property cases.
• Research Assistant for Dean O’Rourke & Prof. Meurer

  Boston University School of Law

  2012.06-2013.03

  (10 months)

  Reviewed and revised an old version of copyright casebook. Outlined more than twenty law review articles on non-practicing entities and the economic models.
• Research Fellow,Neuroscience Dept

  Albert Einstein College of Medicine

  2010.01-2011.08

  (2 years)

  Conducted research on neurophysiology, imaging, and neuroscience.
• Teaching Assistant & Research Assistant,Biology Dept, US

  Rensselaer Polytechnic Institute

  2005.08-2009.06

  (4 years)

  Conducted research on gene knockdown, disease models, molecular biology, and sequencing.

Educational experience

• Boston University School of Law

  Juris Doctor

  2011.09-2014.05

  (3 years)

  Note Editor, American Journal of Law and Medicine; Treasurer, Intellectual Property Law Society; Treasurer, China Law Society; Edward C. Stone Moot Court Competition.
• Rensselaer Polytechnic Institute (Troy, NY),PhD

  Biology

  2005.08-2009.12

  (4 years)

  Thesis: Functions of ahi1, homolog of the human Joubert syndrome gene, during zebrafish development. President, Graduate Student Association of the Center for Biotechnology and Interdisciplinary Studies. Related coursework: Accounting; Marketing; Innovation and Entrepreneurship.
• Tsinghua University, Beijing, China

  Biological Sciences and Biotechnology

  2001.09-2005.06

  (4 years)

  Distinguished Individual in Social Practice. Scholarship for Significant Academic Improvement.

Certificates

Skills